Orbital Therapeutics has 6 close competitors: Kriya Therapeutics, Encoded Therapeutics, Pelage Pharmaceuticals.
Sector, valuation and status for each competitor.
A private valuation and a public market cap share one column; each row names its basis and date.
Pelage Pharmaceuticals
Biosplice Therapeutics
Life BiosciencesBiopharmaceutical company focused on cell therapy and regenerative medicine
Orbital Therapeutics competes with 6 companies here: Kriya Therapeutics, Encoded Therapeutics, Pelage Pharmaceuticals, Biosplice Therapeutics, Life Biosciences, Retro Biosciences.
Orbital Therapeutics develops RNA medicines that reprogram the immune system in vivo, combining circular and linear RNA engineering, lipid nanoparticle delivery, and AI-driven design.
Orbital Therapeutics is private, so its shares are not available on public markets.
Orbital Therapeutics operates in Biotechnology.
Orbital Therapeutics was founded in 2017.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
